Table of contents

  • Preliminary material
  • Sections
    • Purpose, organisation and management
    • 1.1 Introduction and background
      • Objectives of the MS and MND study
    • 1.2 Study organisation and administration
      • Study Advisory Committee
      • Ethics Committee
      • Expert Neurologist Panel
      • Structure of the report
      • Multiple sclerosis and motor neurone disease
    • 2.1 Multiple sclerosis
      • Epidemiology
      • Signs and symptoms
      • Diagnosis
    • 2.2 Motor neurone disease
      • Epidemiology
      • Signs and symptoms
      • Diagnosis
      • Study design
    • 3.1 Study population
      • 'New veterans' and 'new conditions'
    • 3.2 Survey methods
      • Survey of veterans
      • Survey of general practitioners and hospitals
      • Survey of neurologists
      • Classification of clinical notes
      • Deaths of veterans
    • 3.3 Validation methodology
      • Recalculation of Australian community standards
      • Misallocation of conditions
      • Allocation of non-respondents and not able to be validated responses
      • Results
    • 4.1 Survey response
      • Veterans
      • Doctors
      • Neurologists
    • 4.2 Validation of conditions
      • Panel classification results
      • Veterans' deaths since 1997
      • Validation of MS and MND in veterans
      • Impact of method of allocation of non-respondents and not able to be validated responses
      • 'New veterans' and 'new conditions'
    • 4.3 Conclusion
  • End matter
    • Appendixes
    • Appendix 1
    • Appendix 2
    • Appendix 3
    • Appendix 4
    • Appendix 5
    • El Escorial criteria
    • Rose criteria
    • References